Search research articles
Contact Us
Filters
Showing results (131-140 of 293) with videos related to
Page
of 30
Sort By:
JAMA Surgery
|
April 12, 2023
Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
Olga Kantor, Tari A King, Rachel A Freedman, et al.
Scientific Reports
|
June 2, 2022
Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL
Laura E Martínez, Shelly Lensing, Di Chang, et al.
Frontiers in Neuroengineering
|
July 4, 2012
Stop-event-related potentials from intracranial electrodes reveal a key role of premotor and motor cortices in stopping ongoing movements
M Mattia, S Spadacenta, L Pavone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Laura E Martínez, Shelly Lensing, Di Chang, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292
J A Sparano, S Lipsitz, S Wadler, et al.
Cancer
|
October 1, 1991
Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha
J A Sparano, J P Dutcher, R Kaleya, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer
N Chen, J Q Freeman, S Yarlagadda, et al.
Gynecologic Oncology
|
September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment
Stephanie V Blank, Paul Christos, John P Curtin, et al.
European Journal of Neurology
|
April 29, 2006
Lateralizing value of memory tests in drug-resistant temporal lobe epilepsy
L G Grammaldo, T Giampà, P P Quarato, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 293) with videos related to
Sort By:
Page
of 30
JAMA Surgery
|
April 12, 2023
Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
Olga Kantor, Tari A King, Rachel A Freedman, et al.
Scientific Reports
|
June 2, 2022
Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL
Laura E Martínez, Shelly Lensing, Di Chang, et al.
Frontiers in Neuroengineering
|
July 4, 2012
Stop-event-related potentials from intracranial electrodes reveal a key role of premotor and motor cortices in stopping ongoing movements
M Mattia, S Spadacenta, L Pavone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Laura E Martínez, Shelly Lensing, Di Chang, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292
J A Sparano, S Lipsitz, S Wadler, et al.
Cancer
|
October 1, 1991
Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha
J A Sparano, J P Dutcher, R Kaleya, et al.
American Journal of Clinical Oncology
|
September 10, 2009
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma
Anthony P Lam, Joseph A Sparano, Vincent Vinciguerra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer
N Chen, J Q Freeman, S Yarlagadda, et al.
Gynecologic Oncology
|
September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment
Stephanie V Blank, Paul Christos, John P Curtin, et al.
European Journal of Neurology
|
April 29, 2006
Lateralizing value of memory tests in drug-resistant temporal lobe epilepsy
L G Grammaldo, T Giampà, P P Quarato, et al.
Page
of 30